PeptideDB

Anticancer agent 112

CAS: 2495321-37-2 F: C27H32ClN7O W: 506.04

Anticancer agent 112 is a potent anti-cancer agent for cancer research, extracted from patent WO2020198567.
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Anticancer agent 112 is a potent anti-cancer agent for cancer research, extracted from patent WO2020198567[1].
Name Anticancer agent 112
CAS 2495321-37-2
Formula C27H32ClN7O
Molar Mass 506.04
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Reference [1]. Eamon Comer, et al. Quinoline derivatives and their use for the treatment of cancer. Patent WO2020198567

MAT2A-IN-10

Tau protein aggregation-IN-1

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.